Lymphocytes B-cells T-cells Natural killer cells Interferon-activated or cytokine-activated lymphocytes

Industry

CPC
A61K35/17

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

AHUMAN NECESSITIES A61Medical science A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Current Industry

A61K35/17Lymphocytes B-cells T-cells Natural killer cells Interferon-activated or cytokine-activated lymphocytes

Industries

Patents Grantslast 30 patents

Information Patent Grant
Human Kynureninase enzymes and uses thereof
- Patent number 12,144,828
- Issue date Nov 19, 2024
- Board of Regents, The University of Texas System
- George Georgiou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for car T cell therapy
- Patent number 12,144,850
- Issue date Nov 19, 2024
- Purdue Research Foundation
- Philip Stewart Low
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T-cell modulatory multimeric polypeptides and methods of use thereof
- Patent number 12,145,973
- Issue date Nov 19, 2024
- Cue Biopharma, Inc.
- Ronald D. Seidel
- G01 - MEASURING TESTING
Information Patent Grant
Anti-PTK7 immune cell cancer therapy
- Patent number 12,146,157
- Issue date Nov 19, 2024
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment and diagnosis of inflammatory disorders
- Patent number 12,146,138
- Issue date Nov 19, 2024
- Zhenglun Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for obtaining regulatory t cells and uses thereof
- Patent number 12,146,159
- Issue date Nov 19, 2024
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Carole Guillonneau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified A1-A2 domains of non-natural NKG2D ligands that bind non-n...
- Patent number 12,145,976
- Issue date Nov 19, 2024
- Xyphos Biosciences Inc.
- Kaman C. Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunosuppressive antigen-specific chimeric antigen receptor Treg c...
- Patent number 12,144,829
- Issue date Nov 19, 2024
- The University of Toledo
- Juan Carlos Jaume
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating EGFRvIII expressing glioblastomas
- Patent number 12,144,826
- Issue date Nov 19, 2024
- The Regents of the University of California
- Wendell A. Lim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Regulatory T cells targeted by lymphotoxin alpha blocking agent and...
- Patent number 12,146,160
- Issue date Nov 19, 2024
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- Magali Irla
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cellular immunotherapy for repetitive administration
- Patent number 12,144,825
- Issue date Nov 19, 2024
- Cellectis
- David Sourdive
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ROR1 targeting chimeric antigen receptor
- Patent number 12,144,827
- Issue date Nov 19, 2024
- LYELL IMMUNOPHARMA, INC.
- Spencer Park
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
EphA3 directed CAR-T cells for treatment of tumors
- Patent number 12,139,544
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Cameron Durrant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified chimeric receptors and related compositions and methods
- Patent number 12,139,526
- Issue date Nov 12, 2024
- Juno Therapeutics, Inc.
- Lucas James Thompson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated ca...
- Patent number 12,139,523
- Issue date Nov 12, 2024
- Duke University
- Xiao-Fan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody inducing immune tolerance, induced lymphocyte, and cell th...
- Patent number 12,139,537
- Issue date Nov 12, 2024
- Junten Bio Co., Ltd.
- Ryu Maeda
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T-cells comprising two different chimeric antigen receptors and use...
- Patent number 12,139,522
- Issue date Nov 12, 2024
- THE MEDICAL RESEARCH INFRASTRUCTURE AND HEAL SERVICED FUND OF THE TEL AVIV ME...
- Zelig Eshhar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...
- Patent number 12,139,538
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immune cell compositions and methods of use
- Patent number 12,139,524
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Prasad S. Adusumilli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cells derived from umbilical cord blood
- Patent number 12,134,782
- Issue date Nov 5, 2024
- Abraham J and Phyllis Katz Cord Blood Foundation
- Mary Laughlin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti third party central memory t cells, methods of producing same...
- Patent number 12,133,866
- Issue date Nov 5, 2024
- Yeda Research and Development Co. Ltd.
- Yair Reisner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal anti-CD22 chimeric antigen receptor engineered immune cells
- Patent number 12,133,867
- Issue date Nov 5, 2024
- Cellectis SA
- Julianne Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions targeting GABRA2 and methods for diagnosis and treatme...
- Patent number 12,134,650
- Issue date Nov 5, 2024
- Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Benjamin Dekel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using chimeric antigen receptor and protein kin...
- Patent number 12,128,069
- Issue date Oct 29, 2024
- The Trustees of the University of Pennsylvania
- Steven M. Albelda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Blockade of CD2 surface expression and expression of chimeric antig...
- Patent number 12,129,485
- Issue date Oct 29, 2024
- National University of Singapore
- Dario Campana
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Natural killer cell containing exogenous mitochondrium and pharmace...
- Patent number 12,128,070
- Issue date Oct 29, 2024
- PAEAN BIOTECHNOLOGY INC.
- Kyuboem Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors and uses thereof
- Patent number 12,121,539
- Issue date Oct 22, 2024
- BIOSCEPTRE (AUST) PTY LTD
- Justin Taylor Coombs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
BCMA chimeric antigen receptor based on single domain antibody and...
- Patent number 12,121,542
- Issue date Oct 22, 2024
- SHENZHEN PREGENE BIOPHARMA CO. LTD.
- Jishuai Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,121,572
- Issue date Oct 22, 2024
- Immatics Biotechnologies GmbH
- Toni Weinschenk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of redirecting t cells to treat HIV infection
- Patent number 12,122,820
- Issue date Oct 22, 2024
- The Trustees of the University of Pennsylvania
- James L. Riley
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
- Publication number 20240382572
- Publication date Nov 21, 2024
- COGNATE BIOSERVICES, INC.
- Marnix Leo Bosch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SE...
- Publication number 20240382526
- Publication date Nov 21, 2024
- PRECISION BIOSCIENCES, INC.
- Michael G. Nicholson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYSTEMS AND METHODS FOR CELL CULTURING
- Publication number 20240384211
- Publication date Nov 21, 2024
- FLASKWORKS, LLC
- Shashi K. Murthy
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS
- Publication number 20240384301
- Publication date Nov 21, 2024
- UCL Business LTD
- Hans Stauss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF ENGINEERING IMMUNE CELLS HAVING REDUCED FRATRICIDAL ACTI...
- Publication number 20240382521
- Publication date Nov 21, 2024
- Baylor College of Medicine
- Maksim Mamonkin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR AND CAR-T CELLS THAT BIND BCMA
- Publication number 20240382522
- Publication date Nov 21, 2024
- MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
- Armin Rehm
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL TUMOR-SPECIFIC ANTIGENS FOR CANCER STEM CELLS AND USES THEREOF
- Publication number 20240382590
- Publication date Nov 21, 2024
- UNIVERSITE DE MONTREAL
- Claude PERREAULT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS
- Publication number 20240382577
- Publication date Nov 21, 2024
- The United States of America,as represented by the Secretary,Department of He...
- Christian S. Hinrichs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBIN...
- Publication number 20240382523
- Publication date Nov 21, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATING MULTIPLE MYELOMA
- Publication number 20240382524
- Publication date Nov 21, 2024
- Mayo Foundation for Medical Education and Research
- Latha B. Pathangey
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREAT...
- Publication number 20240382525
- Publication date Nov 21, 2024
- Gavish-Galilee Bio Applications Ltd.
- Michael WEIST
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTO...
- Publication number 20240383965
- Publication date Nov 21, 2024
- The Trustees of the University of Pennsylvania
- Saar Gill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS ME...
- Publication number 20240376442
- Publication date Nov 14, 2024
- SOTIO BIOTECH INC.
- Kathleen McGinness
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFEREN...
- Publication number 20240374640
- Publication date Nov 14, 2024
- Immatics Biotechnologies GmbH
- Ricarda HANNEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
- Publication number 20240376201
- Publication date Nov 14, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CLEAVED CDCP1 AND USES THEREOF
- Publication number 20240376224
- Publication date Nov 14, 2024
- The Regents of the University of California
- James WELLS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMS AND METHODS FOR CELL CULTURING
- Publication number 20240376416
- Publication date Nov 14, 2024
- FLASKWORKS, LLC
- Shashi K. Murthy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING CANCER
- Publication number 20240374605
- Publication date Nov 14, 2024
- Foghorn Therapeutics Inc.
- Ammar Adam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT
- Publication number 20240374641
- Publication date Nov 14, 2024
- The Trustees of the University of Pennsylvania
- Donald M. O'Rourke
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HERV-K ANTIBODY THERAPEUTICS
- Publication number 20240374644
- Publication date Nov 14, 2024
- SunnyBay BioTech, Inc.
- Feng WANG-JOHANNING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXPANSION OF MEMORY NATURAL KILLER CELLS
- Publication number 20240374639
- Publication date Nov 14, 2024
- WUGEN, Inc.
- Ryan Patrick SULLIVAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFEREN...
- Publication number 20240374642
- Publication date Nov 14, 2024
- Immatics Biotechnologies GmbH
- Ricarda HANNEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DNASE1-LIKE 3 AND ITS USE IN THERAPY
- Publication number 20240374643
- Publication date Nov 14, 2024
- Neutrolis, Inc.
- Tobias A. FUCHS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR PROVIDING TUMOUR-SPECIFIC T CELLS
- Publication number 20240376543
- Publication date Nov 14, 2024
- HS DIAGNOMICS GMBH
- Rudolf HAMMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN...
- Publication number 20240374748
- Publication date Nov 14, 2024
- The Regents of the University of California
- Bin Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS
- Publication number 20240374645
- Publication date Nov 14, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYMER COMPOUND FOR SURFACE MODIFICATION TO ENHANCE ANTICANCER IMM...
- Publication number 20240366766
- Publication date Nov 7, 2024
- Dongguk University Industry-Academic Cooperation Foundation
- Kyobum KIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20240366972
- Publication date Nov 7, 2024
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CAR T CELL THERAPY AND IFN GAMMA
- Publication number 20240366662
- Publication date Nov 7, 2024
- CITY OF HOPE
- Darya Alizadeh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Universal Receptor Immune Cell Therapy
- Publication number 20240366665
- Publication date Nov 7, 2024
- Prescient Therapeutics Ltd
- Steven L. Yatomi-Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Lymphocytes B-cells T-cells Natural killer cells Interferon-activated or cytokine-activated lymphocytes

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Human Kynureninase enzymes and uses thereof

Methods and compositions for car T cell therapy

T-cell modulatory multimeric polypeptides and methods of use thereof

Anti-PTK7 immune cell cancer therapy

Treatment and diagnosis of inflammatory disorders

Methods for obtaining regulatory t cells and uses thereof

Modified A1-A2 domains of non-natural NKG2D ligands that bind non-n...

Immunosuppressive antigen-specific chimeric antigen receptor Treg c...

Methods of treating EGFRvIII expressing glioblastomas

Regulatory T cells targeted by lymphotoxin alpha blocking agent and...

Cellular immunotherapy for repetitive administration

ROR1 targeting chimeric antigen receptor

EphA3 directed CAR-T cells for treatment of tumors

Modified chimeric receptors and related compositions and methods

Anti-LMP2 TCR-T cell therapy for the treatment of EBV-associated ca...

Antibody inducing immune tolerance, induced lymphocyte, and cell th...

T-cells comprising two different chimeric antigen receptors and use...

Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...

Immune cell compositions and methods of use

T cells derived from umbilical cord blood

Anti third party central memory t cells, methods of producing same...

Universal anti-CD22 chimeric antigen receptor engineered immune cells

Compositions targeting GABRA2 and methods for diagnosis and treatme...

Treatment of cancer using chimeric antigen receptor and protein kin...

Blockade of CD2 surface expression and expression of chimeric antig...

Natural killer cell containing exogenous mitochondrium and pharmace...

Chimeric antigen receptors and uses thereof

BCMA chimeric antigen receptor based on single domain antibody and...

Peptides and combination of peptides for use in immunotherapy again...

Method of redirecting t cells to treat HIV infection

Patents Applicationslast 30 patents

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SE...

SYSTEMS AND METHODS FOR CELL CULTURING

METHOD FOR ENHANCING THE SUPPRESSIVE PROPERTIES OF TREG CELLS

METHODS OF ENGINEERING IMMUNE CELLS HAVING REDUCED FRATRICIDAL ACTI...

CHIMERIC ANTIGEN RECEPTOR AND CAR-T CELLS THAT BIND BCMA

NOVEL TUMOR-SPECIFIC ANTIGENS FOR CANCER STEM CELLS AND USES THEREOF

METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS

OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBIN...

TREATING MULTIPLE MYELOMA

CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREAT...

COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTO...

CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS ME...

PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFEREN...

COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS

ANTIBODIES AGAINST CLEAVED CDCP1 AND USES THEREOF

SYSTEMS AND METHODS FOR CELL CULTURING

METHODS OF TREATING CANCER

GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT

HERV-K ANTIBODY THERAPEUTICS

EXPANSION OF MEMORY NATURAL KILLER CELLS

PEPTIDES DISPLAYED BY HLA FOR USE IN IMMUNOTHERAPY AGAINST DIFFEREN...

DNASE1-LIKE 3 AND ITS USE IN THERAPY

METHOD FOR PROVIDING TUMOUR-SPECIFIC T CELLS

TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN...

BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS

POLYMER COMPOUND FOR SURFACE MODIFICATION TO ENHANCE ANTICANCER IMM...

Chimeric Antigen Receptor-Modified NK-92 Cells

CAR T CELL THERAPY AND IFN GAMMA

Universal Receptor Immune Cell Therapy